noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Amazon.com Inc.

INCORRECT CARGO CARRYING CAPACITY ON LABEL
Amazon.com Inc.

Starter Motor May Overheat and Cause a Fire Fire increases the risk of[...]
City of Alexandria, VA

Alexandria to Welcome 'Walk for Peace' as Monks Travel Through City

Healthcare

Liquidia Corporation

04/22/2025 | Press release | Distributed by Public on 04/22/2025 05:31

Material Event (Form 8-K)

Item 8.01

Other Events.

On April 21, 2025, Liquidia Technologies, Inc., a wholly-owned subsidiary of Liquidia Corporation, a Delaware corporation, filed a patent infringement action against United Therapeutics Corporation in the United States District Court for the Middle District of North Carolina alleging the infringement by United Therapeutics of U.S. Patent No. 10,898,494, entitled "Dry powder treprostinil for the treatment of pulmonary hypertension."

Liquidia Corporation published this content on April 22, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on April 22, 2025 at 11:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]